Zhi Tong Cai Jing·2025-12-18 11:31Group 1 - WuXi Lux Holding has signed a Subscription Agreement to invest €10 million in a fund managed by Jeito Capital, representing 1.07% of the total fund size [1] - Following the agreements, WuXi Lux Holding will hold a total of €30 million in A-class shares, accounting for 3.22% of the total fund size, which has raised approximately €931 million to date [2] - The investment fund, established under French law, targets innovative companies in the biopharmaceutical sector with potential to become global leaders, focusing on early-stage companies with clear clinical needs and commercialization potential [2] Group 2 - Jeito Capital's investment management team possesses strong investment and portfolio management capabilities, with extensive experience in managing biopharmaceutical companies, which can provide critical growth capital and operational guidance to European biotech startups [3] - The investment will enhance the company's understanding of the latest developments in the European biopharmaceutical sector, providing strategic insights for market expansion [3] - The investment will not significantly impact the company's financial condition or operating results, as it will be funded with the company's own resources while ensuring sufficient capital for daily operations [3]